Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN PHARMA

15.700
+0.000
Volume:5.67M
Turnover:88.32M
Market Cap:41.81B
PE:14.21
High:15.880
Open:15.520
Low:15.340
Close:15.700
Loading ...

Shanghai Fosun Pharmaceutical Raises Stake in United Health Insurance; Shares Rise

MT Newswires Live
·
01 Apr

Fosun Pharmaceutical-Owned Gland Pharma to Invest 1.6 Billion Yuan in Indian Mutual Funds, Bonds

MT Newswires Live
·
26 Mar

China's NAFMII Accepts Fosun Pharma's Application to Issue Up to 10 Billion Yuan Bonds

MT Newswires Live
·
26 Mar

Press Release: Fosun Pharma Announces 2024 Annual Results

Dow Jones
·
26 Mar

Shanghai Fosun Pharmaceutical (Group)'s Subsidiary PNH Drug Gets NMPA's Nod for Clinical Trials; Shares Rise 4%

MT Newswires Live
·
14 Mar

Fosun Pharma Gets Clinical Trial Approval for Blood Disorder Drug

MT Newswires Live
·
14 Mar

Fosun Pharma Unit Gets China Nod to Register Foritinib Succinate Capsules

MT Newswires Live
·
07 Mar

Chinese Regulator Approves Shanghai Fosun Pharmaceutical's Vaccine for Clinical Trials

MT Newswires Live
·
04 Mar

Fosun Pharmaceutical Secures Clinical Trial Approval for Colorectal Cancer Treatment

MT Newswires Live
·
28 Feb

Fosun Pharmaceutical Gets Marketing Authorization for Chronic Kidney Disease Drug

MT Newswires Live
·
27 Feb

Fosun Pharmaceutical Unit Gets Chinese Regulator's Nod for Chronic Kidney Disease Tablets

MT Newswires Live
·
26 Feb

Fosun Pharmaceutical Unit Gets China Nod for Lung Diseases Drug

MT Newswires Live
·
26 Feb

Fosun Pharmaceutical Unit Gets China Nod for Colon Cleansing Granules

MT Newswires Live
·
26 Feb

BRIEF-Shanghai Fosun Pharma's Unit Received Marketing Registration Approval From NMPA China For Compound Sodium Picosulfate Granules

Reuters
·
26 Feb

BRIEF-Anhui Sunhere Says Shareholder Shanghai Fosun Pharma To Unload Up To 3% Stake

Reuters
·
23 Feb

Anhui Sunhere Says Shareholder Shanghai Fosun Pharmaceutical Plans to Unload up to 3% Stake in Three Months

THOMSON REUTERS
·
23 Feb

Fosun Pharma Unit to Boost Stake in Medical Services Firm with Additional Investment

MT Newswires Live
·
21 Feb

Fosun Pharmaceutical Gets US FDA Approval for HLX99 Clinical Trials

MT Newswires Live
·
11 Feb

Chinese regulator Accepts New Drug Applications from Shanghai Fosun Pharmaceutical's Two Subsidiaries

MT Newswires Live
·
10 Feb

Fosun Pharma Unit Gets China Clinical Trial Approval for COPD Treatment

MT Newswires Live
·
07 Feb